{
    "analytics_identifier":  null,
    "base_path":  "/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
    "content_id":  "55151b40-ca0a-4d47-a71b-b5f9cb07811d",
    "description":  "Guidance on the 150-day assessment timeline for high-quality marketing authorisation applications including information on how to apply.",
    "details":  {
                    "attachments":  [

                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\u003ch2 id=\"overview\"\u003e1. Overview \u003c/h2\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e offers a 150-day assessment timeline for all high-quality marketing authorisation applications (\u003cabbr title=\"marketing authorisation applications\"\u003eMAAs\u003c/abbr\u003e), aiming at accelerating the availability of medicines for patients in the UK. \u003c/p\u003e\n\n\u003cp\u003eUnder this process, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will evaluate the application for a marketing authorisation and reach its opinion on approvability within 150 days of submission of a valid application. \u003c/p\u003e\n\n\u003ch2 id=\"eligibility\"\u003e2. Eligibility \u003c/h2\u003e\n\n\u003cp\u003eThe 150-day assessment procedure is available for all high-quality new \u003cabbr title=\"marketing authorisation applications\"\u003eMAAs\u003c/abbr\u003e submitted to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e.  \u003c/p\u003e\n\n\u003ch2 id=\"how-to-apply\"\u003e3. How to apply \u003c/h2\u003e\n\n\u003cp\u003eYou can apply for a marketing authorisation (\u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e) for new active substances and biosimilar products or existing active substances. All applications should be submitted through the \u003ca rel=\"external\" href=\"https://services.intralinks.com/branding/3997623225/?clientID=3997623225\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e submission portal\u003c/a\u003e. \u003c/p\u003e\n\n\u003cp\u003eYou can find out more in our \u003ca href=\"https://www.gov.uk/guidance/register-to-make-submissions-to-the-mhra\" class=\"govuk-link\"\u003eguidance about the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e submission portal\u003c/a\u003e. \u003c/p\u003e\n\n\u003cp\u003eYou should use \u003ca href=\"https://www.gov.uk/government/publications/electronic-application-form-and-cover-letter-tool\" class=\"govuk-link\"\u003eour electronic application form (\u003cabbr title=\"electronic application form\"\u003eeAF\u003c/abbr\u003e) and cover letter tool\u003c/a\u003e to determine what information you need to include in your application. If you do not include the correct information your application will not be validated. \u003c/p\u003e\n\n\u003ch3 id=\"new-active-substances-and-biosimilar-products-applications\"\u003e3.1 New active substances and biosimilar products applications \u003c/h3\u003e\n\n\u003cp\u003eCompanies intending to submit direct national marketing authorisation applications for new active substances and/or biological products must request a pre-submission meeting with the relevant teams at least 3 months before the intended application date. See \u003ca href=\"https://www.gov.uk/guidance/pre-submission-advice-support\" class=\"govuk-link\"\u003eguidance on pre-submissions\u003c/a\u003e.  \u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will operate a ‘fixed submission date’ system to facilitate consultation with the Commission on Human Medicines (\u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e) and will publish a set of dates to facilitate planning the submissions to coordinate with appropriate \u003ca href=\"https://www.gov.uk/government/organisations/commission-on-human-medicines/about/membership\" class=\"govuk-link\"\u003e\u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e meeting dates\u003c/a\u003e. \u003c/p\u003e\n\n\u003cp\u003eBefore you submit your application, you should read our guidance on \u003ca href=\"https://www.gov.uk/guidance/procedures-for-uk-paediatric-investigation-plan-pips\" class=\"govuk-link\"\u003eprocedures for UK paediatric investigation plans (\u003cabbr title=\"Procedures for UK Paediatric Investigation Plans\"\u003ePIPs\u003c/abbr\u003e)\u003c/a\u003e. A UK \u003cabbr title=\"Procedures for UK Paediatric Investigation Plan\"\u003ePIP\u003c/abbr\u003e compliance check (\u003cabbr title=\"compliance check\"\u003eCC\u003c/abbr\u003e) should be completed 60 days before your intended submission.  \u003c/p\u003e\n\n\u003cp\u003eFor medicinal products presented or used with a device component, see \u003ca href=\"https://www.gov.uk/guidance/regulating-medical-devices-in-the-uk\" class=\"govuk-link\"\u003eguidance on regulating medical devices\u003c/a\u003e. \u003c/p\u003e\n\n\u003cp\u003eAccess Consortium work-sharing procedures: If you are considering a national application for either a new active substance, a biosimilar product, or a new indication application, then the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e invites you to consider submission via an \u003ca href=\"https://www.gov.uk/guidance/access-new-active-substance-nas-work-sharing-initiative\" class=\"govuk-link\"\u003eaccess consortium work-sharing procedure\u003c/a\u003e. These procedures allow simultaneous submission to the UK, Australia, Canada, Singapore and/or Switzerland. Potential advantages to companies include: \u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cp\u003esimultaneous submission for access to multiple markets\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003estreamlined process: internationally coordinated review to reduce duplication/burden, joint, consolidated lists of questions capturing the assessment of all agencies\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003epredictability: work-sharing and peer review between agencies, with pre-determined joint international milestones\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003ecompetitive timetables: standard procedure of 180 days (excluding stop-clocks) \u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eflexibility: module 1 will be different between jurisdictions, while minor differences in module 2-5 may also be accepted; separate sovereign decisions at end of procedure \u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eopportunity to make a contribution to innovation in the area of regulation\u003c/p\u003e\n  \u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eFor further information, or to express an interest in an Access Consortium submission, contact \u003ca href=\"mailto:access-mhra@mhra.gov.uk\" class=\"govuk-link\"\u003eaccess-mhra@mhra.gov.uk\u003c/a\u003e. \u003c/p\u003e\n\n\u003ch3 id=\"existing-active-substances-applications\"\u003e3.2 Existing active substances applications \u003c/h3\u003e\n\n\u003cp\u003eIf you are applying for \u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e for an existing active substance (a substance that is not a new active substance) you should read our guidance on \u003ca href=\"https://www.gov.uk/guidance/reference-medicinal-products-rmps-from-1-january-2021\" class=\"govuk-link\"\u003echoosing acceptable reference medicinal products for generic applications and/or bioequivalence (BE) studies\u003c/a\u003e. You should also refer to any \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e product-specific BE guidance for applications. Until and including 31 December 2024, guidance applies only to applications for a GB \u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e (an application only for Great Britain). From 1 January 2025, the guidance will apply to UK-wide applications. \u003c/p\u003e\n\n\u003ch2 id=\"validation\"\u003e4. Validation \u003c/h2\u003e\n\n\u003cp\u003eThe assessment timetable for new active substances and biosimilar products or existing active substances will begin after the validation of the application. \u003c/p\u003e\n\n\u003ch3 id=\"new-active-substances-and-biosimilar-products\"\u003e4.1 New active substances and biosimilar products \u003c/h3\u003e\n\n\u003cp\u003eYou should submit a valid, full application for evaluation. The accompanying cover letter should detail the intention to seek orphan status or \u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e under exceptional circumstances as applicable. \u003c/p\u003e\n\n\u003cp\u003eA valid application/dossier should include common technical modules (\u003cabbr title=\"Common Technical Document\"\u003eCTD\u003c/abbr\u003e modules 2-5) and a UK specific \u003cabbr title=\"Common Technical Document\"\u003eCTD\u003c/abbr\u003e module 1, consisting of an appropriate risk management plan (\u003cabbr title=\"Reference Medicinal Products\"\u003eRMP\u003c/abbr\u003e), UK \u003cabbr title=\"Procedures for UK Paediatric Investigation Plan\"\u003ePIP\u003c/abbr\u003e \u003cabbr title=\"compliance check\"\u003eCC\u003c/abbr\u003e and/or compliance with UK orphan medicines requirements, when applicable. \u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Summary of Product Characteristic\"\u003eSmPC\u003c/abbr\u003e/\u003cabbr title=\"Patient Information Leaflet\"\u003ePIL\u003c/abbr\u003e may be submitted as Word documents in the working documents folder. There is an option to put the UK specific \u003cabbr title=\"Summary of Product Characteristic\"\u003eSmPC\u003c/abbr\u003e \u003cabbr title=\"Patient Information Leaflet\"\u003ePIL\u003c/abbr\u003e/labelling text/mock-ups in the UK specific folder which is available in the \u003cabbr title=\"electronic Common Technical Document\"\u003eeCTD\u003c/abbr\u003e structure. \u003c/p\u003e\n\n\u003cp\u003eApplications that refer to an \u003cabbr title=\"Active Substance Master Files\"\u003eASMF\u003c/abbr\u003e should ensure that the file (including the restricted part) has already been submitted to \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e and a suitable letter of access authorising \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e to make reference to the confidential information in the restricted part of the \u003cabbr title=\"Active Substance Master Files\"\u003eASMF\u003c/abbr\u003e should be provided. \u003c/p\u003e\n\n\u003ch3 id=\"existing-active-substances-applications-1\"\u003e4.2 Existing active substances applications \u003c/h3\u003e\n\n\u003cp\u003eA valid application/dossier should include common technical modules (\u003cabbr title=\"Common Technical Document\"\u003eCTD\u003c/abbr\u003e modules 2-5, as appropriate), a UK specific \u003cabbr title=\"Common Technical Document\"\u003eCTD\u003c/abbr\u003e module1, and an appropriate risk management plan. \u003c/p\u003e\n\n\u003cp\u003eApplications that refer to an \u003cabbr title=\"Active Substance Master Files\"\u003eASMF\u003c/abbr\u003e should ensure that the file has already been submitted to \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e or included in the submission. \u003c/p\u003e\n\n\u003ch2 id=\"fees\"\u003e5. Fees \u003c/h2\u003e\n\n\u003cp\u003eFees will be payable at the appropriate national rate. You can find out more about the fees we charge in the guidance \u003ca href=\"https://www.gov.uk/government/publications/mhra-fees\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e fees\u003c/a\u003e. \u003c/p\u003e\n\n\u003cp\u003eUse the \u003ca rel=\"external\" href=\"https://applicationfeescalculator.mhra.gov.uk/\" class=\"govuk-link\"\u003eFees Calculator\u003c/a\u003e to work out what the fee for your submission will be. You can find out more about how pay your fees in our guidance \u003ca href=\"https://www.gov.uk/guidance/make-a-payment-to-mhra\" class=\"govuk-link\"\u003eMake a payment to \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e\u003c/a\u003e. \u003c/p\u003e\n\n\u003ch2 id=\"assessment\"\u003e6. Assessment  \u003c/h2\u003e\n\n\u003ch3 id=\"new-active-substances-and-biosimilar-products-1\"\u003e6.1 New active substances and biosimilar products \u003c/h3\u003e\n\n\u003cp\u003eThe assessment process includes consultation with the \u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e on fixed dates each month. The \u003ca href=\"https://www.gov.uk/guidance/marketing-authorisation-application-submission-dates-for-150-days-national-and-european-commission-decision-reliance-procedures\" class=\"govuk-link\"\u003esubmission slots\u003c/a\u003e will be linked to the dates of \u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e meetings. The \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e may additionally wish to seek advice or input from therapy area experts (specialty expert groups) during the assessment process. \u003c/p\u003e\n\n\u003cp\u003eThe assessment process will run in two phases totalling 150 days with an intervening clock-off period between phase I and phase II, if required. Assessment phase I will be completed 80 days after the clock starts. Issues arising or requiring clarification from the initial assessment will be raised with the applicant as a letter requesting further information (\u003cabbr title=\"request for information\"\u003eRFI\u003c/abbr\u003e) and should be addressed within the clock-off period of 60 days. \u003c/p\u003e\n\n\u003cp\u003eRequests for extension of the clock-off period for up to another 60 days may be granted only for exceptions. Applicants may contact the assessment team for discussing issues raised in the \u003cabbr title=\"request for information\"\u003eRFI\u003c/abbr\u003e letter. Assessment in phase I will also address eligibility for grant of orphan status. Phase II assessment will commence on receipt of the applicant’s responses. Applicants are recommended to contact the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Assessment Team in advance of the intended date of submission of response to align with \u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e meetings. Based on the assessment, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will provide a decision on approvability of the product by day 150. \u003c/p\u003e\n\n\u003cp\u003eFor new active substances and biosimilar products, the orphan status will be determined at the time of \u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e grant. If orphan status is not agreed and the company wishes to appeal this decision, the grant of a marketing authorisation will only be possible when the appeal process is completed. \u003c/p\u003e\n\n\u003ch3 id=\"existing-active-substances-applications-2\"\u003e6.2 Existing active substances applications \u003c/h3\u003e\n\n\u003cp\u003eThe assessment process will run in two phases totalling 150 days with an intervening clock-off period between phase I and phase II, if required. Assessment phase I will be completed within 80 days after clock start. Concerns arising from the initial assessment will be raised with the applicant as a letter requesting further information (\u003cabbr title=\"request for information\"\u003eRFI\u003c/abbr\u003e). \u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will seek advice from \u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e and/or therapy area experts (specialty expert groups) during the assessment process, as required. All concerns must be fully addressed in the clock-off period of 60 days. Requests for extension of the clock-off for up to another 60 days may be granted under exceptions only. Applicants may contact the assessment team for discussing issues raised in the \u003cabbr title=\"request for information\"\u003eRFI\u003c/abbr\u003e letter. \u003c/p\u003e\n\n\u003cp\u003ePhase II assessment will begin on receipt of the applicant’s responses. Based on the assessment, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will provide an opinion on approvability of the product by day 150, and if positive, will grant the \u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e. \u003c/p\u003e\n\n\u003ch3 id=\"appeals\"\u003e6.3 Appeals \u003c/h3\u003e\n\n\u003cp\u003eIf the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e proposes to refuse to grant the \u003cabbr title=\"marketing authorisation\"\u003eMA\u003c/abbr\u003e based on advice from \u003cabbr title=\"Commission on Human Medicines\"\u003eCHM\u003c/abbr\u003e, there is an opportunity for the applicant to request a review of the decision. The procedure for such review is set out in Schedule 5, and paragraph 11 of Schedule 11, to the Human Medicines Regulations. The \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e decision letter will detail the appeal process and timelines. \u003c/p\u003e\n\n\u003ch3 id=\"publication\"\u003e6.4 Publication \u003c/h3\u003e\n\n\u003cp\u003eConclusion of the assessment will lead to the publication of a UK public assessment report for the product. \u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "Updated with respect to the Windsor Framework and pre-submission advice.",
                                               "public_timestamp":  "2024-12-31T17:01:58.000+00:00"
                                           },
                                           {
                                               "note":  "The email address used to request pre-submission advice AcceleratedandRollingReview@mhra.gov.uk has been replaced with presubmission@mhra.gov.uk",
                                               "public_timestamp":  "2024-04-16T16:15:39.000+01:00"
                                           },
                                           {
                                               "note":  "Added link to Fees Calculator.",
                                               "public_timestamp":  "2024-01-05T10:12:53.000+00:00"
                                           },
                                           {
                                               "note":  "New active substances and biosimilar products applications section updated.",
                                               "public_timestamp":  "2023-06-15T16:14:34.000+01:00"
                                           },
                                           {
                                               "note":  "Update to the Pre-submission meeting section.",
                                               "public_timestamp":  "2022-10-28T15:09:41.000+01:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2020-12-31T00:00:00.000+00:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2020-12-31T00:00:00.000+00:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2020-12-31T00:00:00+00:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                     "base_path":  "/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                     "content_id":  "55151b40-ca0a-4d47-a71b-b5f9cb07811d",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2024-12-31T17:01:58Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "150-day assessment for national applications for medicines",
                                                     "web_url":  "https://www.gov.uk/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                     "withdrawn":  false
                                                 }
                                             ],
                  "document_collections":  [
                                               {
                                                   "api_path":  "/api/content/government/collections/licencing-how-to-apply",
                                                   "api_url":  "https://www.gov.uk/api/content/government/collections/licencing-how-to-apply",
                                                   "base_path":  "/government/collections/licencing-how-to-apply",
                                                   "content_id":  "8a0afebe-d228-4740-af1d-f37c9f6878b3",
                                                   "document_type":  "document_collection",
                                                   "links":  {
                                                                 "documents":  [
                                                                                   {
                                                                                       "api_path":  "/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "base_path":  "/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "content_id":  "55151b40-ca0a-4d47-a71b-b5f9cb07811d",
                                                                                       "document_type":  "detailed_guide",
                                                                                       "links":  {

                                                                                                 },
                                                                                       "locale":  "en",
                                                                                       "public_updated_at":  "2024-12-31T17:01:58Z",
                                                                                       "schema_name":  "detailed_guide",
                                                                                       "title":  "150-day assessment for national applications for medicines",
                                                                                       "web_url":  "https://www.gov.uk/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "withdrawn":  false
                                                                                   }
                                                                               ]
                                                             },
                                                   "locale":  "en",
                                                   "public_updated_at":  "2021-05-04T13:48:00Z",
                                                   "schema_name":  "document_collection",
                                                   "title":  "Licensing: how to apply",
                                                   "web_url":  "https://www.gov.uk/government/collections/licencing-how-to-apply",
                                                   "withdrawn":  false
                                               },
                                               {
                                                   "api_path":  "/api/content/government/collections/medicines-licensing-and-applications",
                                                   "api_url":  "https://www.gov.uk/api/content/government/collections/medicines-licensing-and-applications",
                                                   "base_path":  "/government/collections/medicines-licensing-and-applications",
                                                   "content_id":  "dbfe62cd-82a9-47be-8f5f-926b68241acc",
                                                   "document_type":  "document_collection",
                                                   "links":  {
                                                                 "documents":  [
                                                                                   {
                                                                                       "api_path":  "/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "base_path":  "/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "content_id":  "55151b40-ca0a-4d47-a71b-b5f9cb07811d",
                                                                                       "document_type":  "detailed_guide",
                                                                                       "links":  {

                                                                                                 },
                                                                                       "locale":  "en",
                                                                                       "public_updated_at":  "2024-12-31T17:01:58Z",
                                                                                       "schema_name":  "detailed_guide",
                                                                                       "title":  "150-day assessment for national applications for medicines",
                                                                                       "web_url":  "https://www.gov.uk/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "withdrawn":  false
                                                                                   }
                                                                               ]
                                                             },
                                                   "locale":  "en",
                                                   "public_updated_at":  "2023-09-20T23:00:00Z",
                                                   "schema_name":  "document_collection",
                                                   "title":  "Medicines: licensing and applications",
                                                   "web_url":  "https://www.gov.uk/government/collections/medicines-licensing-and-applications",
                                                   "withdrawn":  false
                                               },
                                               {
                                                   "api_path":  "/api/content/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "api_url":  "https://www.gov.uk/api/content/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "base_path":  "/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "content_id":  "aecc31f9-1d53-4c18-9df4-4e5940323c4f",
                                                   "document_type":  "document_collection",
                                                   "links":  {
                                                                 "documents":  [
                                                                                   {
                                                                                       "api_path":  "/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "base_path":  "/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "content_id":  "55151b40-ca0a-4d47-a71b-b5f9cb07811d",
                                                                                       "document_type":  "detailed_guide",
                                                                                       "links":  {

                                                                                                 },
                                                                                       "locale":  "en",
                                                                                       "public_updated_at":  "2024-12-31T17:01:58Z",
                                                                                       "schema_name":  "detailed_guide",
                                                                                       "title":  "150-day assessment for national applications for medicines",
                                                                                       "web_url":  "https://www.gov.uk/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines",
                                                                                       "withdrawn":  false
                                                                                   }
                                                                               ]
                                                             },
                                                   "locale":  "en",
                                                   "public_updated_at":  "2021-03-30T10:06:39Z",
                                                   "schema_name":  "document_collection",
                                                   "title":  "New guidance and information for industry from the MHRA",
                                                   "web_url":  "https://www.gov.uk/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "withdrawn":  false
                                               }
                                           ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2019-to-2022-johnson-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2019-to-2022-johnson-conservative-government",
                                         "base_path":  "/government/2019-to-2022-johnson-conservative-government",
                                         "content_id":  "4ed901ec-c8ce-42d5-a2aa-6d7f462480df",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2022-09-06T00:00:00+00:00",
                                                         "started_on":  "2019-07-24T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2019 to 2022 Johnson Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2019-to-2022-johnson-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "suggested_ordered_related_items":  [
                                                          {
                                                              "api_path":  "/api/content/guidance/reference-medicinal-products-rmps",
                                                              "api_url":  "https://www.gov.uk/api/content/guidance/reference-medicinal-products-rmps",
                                                              "base_path":  "/guidance/reference-medicinal-products-rmps",
                                                              "content_id":  "d64bf3fc-32f7-4eea-a298-b6a59683a674",
                                                              "document_type":  "detailed_guide",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2024-10-18T15:51:46Z",
                                                              "schema_name":  "detailed_guide",
                                                              "title":  "Reference Medicinal Products (RMPs)",
                                                              "web_url":  "https://www.gov.uk/guidance/reference-medicinal-products-rmps",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/guidance/marketing-authorisation-application-submission-dates-for-150-days-national-and-european-commission-decision-reliance-procedures",
                                                              "api_url":  "https://www.gov.uk/api/content/guidance/marketing-authorisation-application-submission-dates-for-150-days-national-and-european-commission-decision-reliance-procedures",
                                                              "base_path":  "/guidance/marketing-authorisation-application-submission-dates-for-150-days-national-and-european-commission-decision-reliance-procedures",
                                                              "content_id":  "f493c6b2-2bb6-46a8-b51a-014c33751c40",
                                                              "document_type":  "detailed_guide",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2023-09-12T09:15:44Z",
                                                              "schema_name":  "detailed_guide",
                                                              "title":  "Marketing Authorisation Application submission dates for 150-days national and European Commission decision reliance procedures",
                                                              "web_url":  "https://www.gov.uk/guidance/marketing-authorisation-application-submission-dates-for-150-days-national-and-european-commission-decision-reliance-procedures",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/guidance/types-of-application-legal-basis",
                                                              "api_url":  "https://www.gov.uk/api/content/guidance/types-of-application-legal-basis",
                                                              "base_path":  "/guidance/types-of-application-legal-basis",
                                                              "content_id":  "81dd8ca0-9397-4443-9d0c-4c63115d12f0",
                                                              "document_type":  "detailed_guide",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2021-03-31T13:11:42Z",
                                                              "schema_name":  "detailed_guide",
                                                              "title":  "Types of application (legal basis)",
                                                              "web_url":  "https://www.gov.uk/guidance/types-of-application-legal-basis",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/guidance/decentralised-and-mutual-recognition-reliance-procedure-for-marketing-authorisations",
                                                              "api_url":  "https://www.gov.uk/api/content/guidance/decentralised-and-mutual-recognition-reliance-procedure-for-marketing-authorisations",
                                                              "base_path":  "/guidance/decentralised-and-mutual-recognition-reliance-procedure-for-marketing-authorisations",
                                                              "content_id":  "ad71be1e-caef-43f2-978c-5f818280f6cd",
                                                              "document_type":  "detailed_guide",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2021-02-23T11:18:25Z",
                                                              "schema_name":  "detailed_guide",
                                                              "title":  "Decentralised and mutual recognition reliance procedure for marketing authorisations",
                                                              "web_url":  "https://www.gov.uk/guidance/decentralised-and-mutual-recognition-reliance-procedure-for-marketing-authorisations",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/collections/licencing-how-to-apply",
                                                              "api_url":  "https://www.gov.uk/api/content/government/collections/licencing-how-to-apply",
                                                              "base_path":  "/government/collections/licencing-how-to-apply",
                                                              "content_id":  "8a0afebe-d228-4740-af1d-f37c9f6878b3",
                                                              "document_type":  "document_collection",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2021-05-04T13:48:00Z",
                                                              "schema_name":  "document_collection",
                                                              "title":  "Licensing: how to apply",
                                                              "web_url":  "https://www.gov.uk/government/collections/licencing-how-to-apply",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "content_id":  "f4f28e9d-2050-45fb-ab76-78c0345670da",
                                     "details":  {
                                                     "internal_name":  "Marketing authorisations, variations and licensing guidance [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:21Z",
                                     "schema_name":  "taxon",
                                     "title":  "Marketing authorisations, variations and licensing guidance",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/government/brexit",
                                     "api_url":  "https://www.gov.uk/api/content/government/brexit",
                                     "base_path":  "/government/brexit",
                                     "content_id":  "d6c2de5d-ef90-45d1-82d4-5f2438369eea",
                                     "description":  "Find out how new Brexit rules apply to things like travel and doing business with Europe.",
                                     "details":  {
                                                     "internal_name":  "Brexit",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "/government/collections/brexit-guidance",
                                                     "visible_to_departmental_editors":  true
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/government/all",
                                                                             "api_url":  "https://www.gov.uk/api/content/government/all",
                                                                             "base_path":  "/government/all",
                                                                             "content_id":  "e48ab80a-de80-4e83-bf59-26316856a5f9",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Government",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2018-09-16T20:29:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Government",
                                                                             "web_url":  "https://www.gov.uk/government/all",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2024-11-14T17:47:34Z",
                                     "schema_name":  "taxon",
                                     "title":  "Brexit",
                                     "web_url":  "https://www.gov.uk/government/brexit",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2024-12-31T17:01:58+00:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "21-1735664518.150-10.13.20.208-2365",
    "publishing_scheduled_at":  "2021-03-30T15:30:00+01:00",
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  2,
    "schema_name":  "detailed_guide",
    "title":  "150-day assessment for national applications for medicines",
    "updated_at":  "2024-12-31T17:01:58+00:00",
    "withdrawn_notice":  {

                         }
}
